Physician profile
Derik Geist
NPI 1104080563
$13,963.74
in general payments reported to CMS, 2019-2025
10 companies · $3,006 in 2025
The $3,006 reported for 2025 was more than what 75% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,864 · 2020: $1,195 · 2021: $1,214 · 2022: $2,491 · 2023: $1,617 · 2024: $2,576 · 2025: $3,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,473 · Food and Beverage: $2,361 · Consulting Fee: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,473.04 |
| Food and Beverage | $2,360.51 |
| Consulting Fee | $365.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,427.77 | 2019-2025 | |
| Mid-Atlantic Surgical Systems, LLC | $4,723.76 | 2019-2025 | |
| Catalyst Orthoscience | $2,395.76 | 2023-2025 | R1 Reverse Total Shoulder, Archer 3d Software, Csr & R1 Reverse Total Shoulder Systems |
| Encore Medical, Lp | $900.73 | 2019-2024 | Djo Surgical |
| Smith+Nephew, INC. | $184.71 | 2019 | |
| Zimmer Biomet Holdings, INC. | $103.52 | 2019 | |
| Davol INC. | $95.40 | 2023 | Arista Ah Flexitip |
| Linvatec Corporation | $92.71 | 2024 | Biobrace 23mm |
| Vericel Corporation | $20.29 | 2025 | Maci |
| Depuy Synthes Sales INC. | $19.09 | 2023 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derik Geist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.